Amgros is a stakeholder with the 5 regions as stakeholders. With a view to providing stakeholders' hospital pharmacies with medicinal products and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I/S wishes to conclude framework agreements for the medicinal products listed in Title II.2.4. The framework agreements are non-exclusive. Amgros I/S resells the medicines to the hospital pharmacies at Amgros I/S's purchase price with a supplement. Framework agreements are concluded without purchasing obligation and hospital pharmacies in the regions are not obliged to use Amgros' framework agreements.
The tender number includes the following medicines:
Tender No: 1,
ATC Code: M05BX07,
Generic Name: Vosoritid,
Dispensing form: Injection liquid,
Strength: 0.4 mg,
Unit value: 0,7 mg,
Volume in units: 9 999.
Tender No: 1,
ATC Code: M05BX07,
Generic Name: Vosoritid,
Dispensing form: Injection liquid,
Strength: 0.56 mg,
Unit value: 0,7 mg,
Volume in units: 9 999.
Tender No: 1,
ATC Code: M05BX07,
Generic Name: Vosoritid,
Dispensing form: Injection liquid,
Strength: 1.2 mg,
Unit value: 0,7 mg,
Volume in units: 9 999.
Each tender number shall be considered a stand-alone subcontract and shall be offered independently of the other tender numbers. Thus, a vendor may choose to offer at one, more or all tender numbers, and allocation is made separately for each offer number. Please refer to the tender conditions, including the submission of tenders under the individual tender numbers.
Under the term "quantity in units" above, an estimated consumption of the medicinal products is given under the tender number, but actual consumption may differ significantly from this. This must be expected by suppliers. The reason for this is that these are medicines for patient treatment in public hospitals, where the patient's needs must be met. The medicines offered are also subject to one or more assessments from the Danish Medicines Council, and the consumption of the various medicines may be significantly affected by this. For further details, please refer to the specifications and the framework agreement.
The total value estimated in paragraph II.1.5 above is equal to the maximum value of the lot.